Special Report

5 things pharmacies should consider before the hydrocodone rescheduling deadline

Now that the Drug Enforcement Agency has tightened restrictions on hydrocodone combination products by reclassifying them as Schedule II controlled substances, how should pharmacies prepare for the change? Jason Poquette, BPharm, RPh, author of The Honest Apothecary blog, discusses five challenges pharmacies are likely to face.

"Bean counters in corporate offices may notice some decline in weekly prescriptions and get anxious, putting more pressure on pharmacists and pharmacies."
—Jason Poquette, BPharm, RPh

RELATED COVERAGE

• LIVE SPECIAL EVENT: Medication Management for Patients with Diabetes CPE Series

• DEA tightens restrictions on hydrocodone combination products

• FDA defends Zohydro approval in opioid abuse debate

Editorial Questions? Contact the Editorial Team. Click Here.
Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.